Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020): The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy

Tim R. Eijgenraam; Bastiaan J. Boukens; Cornelis J. Boogerd; E. Marloes Schouten; Cees W.A. van de Kolk; Nienke M. Stege; Wouter P. te Rijdt; Edgar T. Hoorntje; Paul A. van der Zwaag; Eva van Rooij; J. Peter van Tintelen; Maarten P. van den Berg; Peter van der Meer; Jolanda van der Velden; Herman H.W. Silljé; Rudolf A. de Boer

doi:10.1038/s41598-020-70780-x

Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020): The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy

Tim R. Eijgenraam, Bastiaan J. Boukens, Cornelis J. Boogerd, E. Marloes Schouten, Cees W.A. van de Kolk, Nienke M. Stege, Wouter P. te Rijdt, Edgar T. Hoorntje, Paul A. van der Zwaag, Eva van Rooij, J. Peter van Tintelen, Maarten P. van den Berg, Peter van der Meer, Jolanda van der Velden, Herman H.W. Silljé, Rudolf A. de Boer^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

2 Downloads (Pure)

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Original language	English
Article number	16710
Journal	Scientific Reports
Volume	10
Issue number	1
DOIs	https://doi.org/10.1038/s41598-020-70780-x
Publication status	Published - 2 Oct 2020

Access to Document

10.1038/s41598-020-70780-x

s41598-020-70780-xFinal published version, 732 KB

Fingerprint

Dive into the research topics of 'Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020): The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy'. Together they form a unique fingerprint.

Cite this

Eijgenraam, T. R., Boukens, B. J., Boogerd, C. J., Schouten, E. M., van de Kolk, C. W. A., Stege, N. M., te Rijdt, W. P., Hoorntje, E. T., van der Zwaag, P. A., van Rooij, E., van Tintelen, J. P., van den Berg, M. P., van der Meer, P., van der Velden, J., Silljé, H. H. W., & de Boer, R. A. (2020). Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020): The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy. Scientific Reports, 10(1), Article 16710. https://doi.org/10.1038/s41598-020-70780-x

Eijgenraam, Tim R. ; Boukens, Bastiaan J. ; Boogerd, Cornelis J. et al. / Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020) : The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy. In: Scientific Reports. 2020 ; Vol. 10, No. 1.

@article{07031f6125e743e3aab79ba0acc1222a,

title = "Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020): The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy",

abstract = "An amendment to this paper has been published and can be accessed via a link at the top of the paper.",

author = "Eijgenraam, {Tim R.} and Boukens, {Bastiaan J.} and Boogerd, {Cornelis J.} and Schouten, {E. Marloes} and {van de Kolk}, {Cees W.A.} and Stege, {Nienke M.} and {te Rijdt}, {Wouter P.} and Hoorntje, {Edgar T.} and {van der Zwaag}, {Paul A.} and {van Rooij}, Eva and {van Tintelen}, {J. Peter} and {van den Berg}, {Maarten P.} and {van der Meer}, Peter and {van der Velden}, Jolanda and Sillj{\'e}, {Herman H.W.} and {de Boer}, {Rudolf A.}",

year = "2020",

month = oct,

day = "2",

doi = "10.1038/s41598-020-70780-x",

language = "English",

volume = "10",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

number = "1",

}

Eijgenraam, TR, Boukens, BJ, Boogerd, CJ, Schouten, EM, van de Kolk, CWA, Stege, NM, te Rijdt, WP, Hoorntje, ET, van der Zwaag, PA, van Rooij, E , van Tintelen, JP, van den Berg, MP, van der Meer, P, van der Velden, J, Silljé, HHW & de Boer, RA 2020, 'Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020): The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy', Scientific Reports, vol. 10, no. 1, 16710. https://doi.org/10.1038/s41598-020-70780-x

Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020): The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy. / Eijgenraam, Tim R.; Boukens, Bastiaan J.; Boogerd, Cornelis J. et al.
In: Scientific Reports, Vol. 10, No. 1, 16710, 02.10.2020.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020)

T2 - The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy

AU - Eijgenraam, Tim R.

AU - Boukens, Bastiaan J.

AU - Boogerd, Cornelis J.

AU - Schouten, E. Marloes

AU - van de Kolk, Cees W.A.

AU - Stege, Nienke M.

AU - te Rijdt, Wouter P.

AU - Hoorntje, Edgar T.

AU - van der Zwaag, Paul A.

AU - van Rooij, Eva

AU - van Tintelen, J. Peter

AU - van den Berg, Maarten P.

AU - van der Meer, Peter

AU - van der Velden, Jolanda

AU - Silljé, Herman H.W.

AU - de Boer, Rudolf A.

PY - 2020/10/2

Y1 - 2020/10/2

N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper.

AB - An amendment to this paper has been published and can be accessed via a link at the top of the paper.

UR - http://www.scopus.com/inward/record.url?scp=85091949835&partnerID=8YFLogxK

U2 - 10.1038/s41598-020-70780-x

DO - 10.1038/s41598-020-70780-x

M3 - Comment/Letter to the editor

C2 - 33009422

AN - SCOPUS:85091949835

SN - 2045-2322

VL - 10

JO - Scientific Reports

JF - Scientific Reports

IS - 1

M1 - 16710

ER -

Eijgenraam TR, Boukens BJ, Boogerd CJ, Schouten EM, van de Kolk CWA, Stege NM et al. Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020): The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy. Scientific Reports. 2020 Oct 2;10(1):16710. doi: 10.1038/s41598-020-70780-x

Abstract

Access to Document

Other files and links

Fingerprint

Cite this